Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC

Geert A. Simkens, Thijs R. van Oudheusden, Daan Nieboer, Ewout W. Steyerberg, Harm J. Rutten, Misha D. Luyer, Simon W. Nienhuijs, Ignace H. de Hingh*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Web of Science)


With the introduction of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), long-term survival can be achieved in selected patients with colorectal peritoneal metastases (PM). Patient selection and outcome may be improved significantly with a tool that adequately predicts survival in these patients. This study was designed to validate the peritoneal surface disease severity score (PSDSS) in patients with colorectal PM treated with CRS?+?HIPEC. If performance of the PSDSS was suboptimal (c?
Original languageEnglish
Pages (from-to)4214-4221
JournalAnnals of Surgical Oncology
Issue number13
Publication statusPublished - Dec 2016

Cite this